First Time Loading...
S

Shin Nippon Biomedical Laboratories Ltd
TSE:2395

Watchlist Manager
Shin Nippon Biomedical Laboratories Ltd
TSE:2395
Watchlist
Price: 1 542 JPY Market Closed
Updated: May 1, 2024

Shin Nippon Biomedical Laboratories Ltd
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Shin Nippon Biomedical Laboratories Ltd
Operating Income Peer Comparison

Comparables:
2309
2370
4880
2183
7079

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
S
Shin Nippon Biomedical Laboratories Ltd
TSE:2395
Operating Income
¥4B
CAGR 3-Years
21%
CAGR 5-Years
37%
CAGR 10-Years
N/A
CMIC Holdings Co Ltd
TSE:2309
Operating Income
¥5.5B
CAGR 3-Years
30%
CAGR 5-Years
5%
CAGR 10-Years
4%
Medinet Co Ltd
TSE:2370
Operating Income
-¥1.4B
CAGR 3-Years
-10%
CAGR 5-Years
1%
CAGR 10-Years
-4%
CellSource Co Ltd
TSE:4880
Operating Income
¥1.2B
CAGR 3-Years
43%
CAGR 5-Years
33%
CAGR 10-Years
N/A
Linical Co Ltd
TSE:2183
Operating Income
¥1.2B
CAGR 3-Years
50%
CAGR 5-Years
-5%
CAGR 10-Years
4%
WDB coco Co Ltd
TSE:7079
Operating Income
¥1.1B
CAGR 3-Years
32%
CAGR 5-Years
30%
CAGR 10-Years
N/A

See Also

What is Shin Nippon Biomedical Laboratories Ltd's Operating Income?
Operating Income
4B JPY

Based on the financial report for Dec 31, 2023, Shin Nippon Biomedical Laboratories Ltd's Operating Income amounts to 4B JPY.

What is Shin Nippon Biomedical Laboratories Ltd's Operating Income growth rate?
Operating Income CAGR 5Y
37%

Over the last year, the Operating Income growth was -15%. The average annual Operating Income growth rates for Shin Nippon Biomedical Laboratories Ltd have been 21% over the past three years , 37% over the past five years .